Complete cytoreduction after six cycles of Neo-adjuvant chemotherapy confers a survival benefit in advanced ovarian cancer.

Mapping Intimacies ◽

10.26226/morressier.59ba7298d462b80296ca2058 ◽

2017 ◽

Author(s):

Phillips Andrew

Keyword(s):

Ovarian Cancer ◽

Adjuvant Chemotherapy ◽

Survival Benefit ◽

Advanced Ovarian Cancer ◽

Complete Cytoreduction ◽

Neo Adjuvant Chemotherapy

Download Full-text

Complete cytoreduction after five or more cycles of neo-adjuvant chemotherapy confers a survival benefit in advanced ovarian cancer

European Journal of Surgical Oncology ◽

10.1016/j.ejso.2018.01.097 ◽

2018 ◽

Vol 44 (6) ◽

pp. 760-765 ◽

Author(s):

Andrew Phillips ◽

Sudha Sundar ◽

Kavita Singh ◽

James Nevin ◽

Ahmed Elattar ◽

...

Keyword(s):

Ovarian Cancer ◽

Adjuvant Chemotherapy ◽

Survival Benefit ◽

Advanced Ovarian Cancer ◽

Complete Cytoreduction ◽

Neo Adjuvant Chemotherapy

Download Full-text

NOVEL BIOMARKER HE4 IN PREDICTING OPTIMAL CYTOREDUCTION AFTER NEO-ADJUVANT CHEMOTHERAPY (NACT) FOR ADVANCED OVARIAN CANCER

10.26226/morressier.5770e29dd462b80290b4c2b7 ◽

2016 ◽

Author(s):

Francesco Plotti

Keyword(s):

Ovarian Cancer ◽

Adjuvant Chemotherapy ◽

Advanced Ovarian Cancer ◽

Optimal Cytoreduction ◽

Neo Adjuvant Chemotherapy

Download Full-text

507 Significant survival benefit is associated with complete cytoreduction in delayed cytoreductive surgery for advanced ovarian cancer

10.1136/ijgc-2021-esgo.417 ◽

2021 ◽

Author(s):

V Cassar ◽

S Rundle ◽

P Korompelis ◽

A Fisher ◽

A Kucukmetin ◽

...

Keyword(s):

Ovarian Cancer ◽

Cytoreductive Surgery ◽

Survival Benefit ◽

Advanced Ovarian Cancer ◽

Complete Cytoreduction ◽

Significant Survival Benefit ◽

Significant Survival

Download Full-text

Laparoscopic Interval Debulking Surgery Including Systemic Lymphadenectomy After Neo-Adjuvant Chemotherapy in Advanced Ovarian Cancer

Journal of Minimally Invasive Gynecology ◽

10.1016/j.jmig.2018.09.159 ◽

2018 ◽

Vol 25 (7) ◽

pp. S62

Author(s):

J. Eom ◽

J. Choi ◽

J. Bae ◽

W. Lee ◽

U. Jung

Keyword(s):

Ovarian Cancer ◽

Adjuvant Chemotherapy ◽

Advanced Ovarian Cancer ◽

Debulking Surgery ◽

Interval Debulking Surgery ◽

Neo Adjuvant Chemotherapy

Download Full-text

Neo-Adjuvant chemotherapy for advanced ovarian cancer

Cancer Treatment An Update ◽

10.1007/978-2-8178-0765-2_94 ◽

1994 ◽

pp. 453-459

Author(s):

Y. Shimizu ◽

S. Umezawa ◽

N. Takeshima ◽

T. Kato ◽

K. Hasumi

Keyword(s):

Ovarian Cancer ◽

Adjuvant Chemotherapy ◽

Advanced Ovarian Cancer ◽

Neo Adjuvant Chemotherapy

Download Full-text

Randomized Double Blind Placebo-Controlled Phase Ii Trial of Nintedanib Versus Placebo in Advanced Ovarian Cancer (Oc) Patients Treated with Neo-Adjuvant Chemotherapy (Nacx) and Interval Debulking Surgery (Ids):The Chiva Trial from Gineco

Annals of Oncology ◽

10.1093/annonc/mdu338.63 ◽

2014 ◽

Vol 25 ◽

pp. iv324

Author(s):

G. Ferron ◽

A. Lesoin ◽

I.L. Ray-Coquard ◽

F. Joly Lobbedez ◽

G. De Rauglaudre ◽

...

Keyword(s):

Ovarian Cancer ◽

Adjuvant Chemotherapy ◽

Phase Ii ◽

Phase Ii Trial ◽

Advanced Ovarian Cancer ◽

Debulking Surgery ◽

Double Blind ◽

Double Blind Placebo ◽

Interval Debulking Surgery ◽

Neo Adjuvant Chemotherapy

Download Full-text

Quality of life of advanced ovarian cancer patients in the randomized phase III study comparing primary debulking surgery versus neo-adjuvant chemotherapy

Gynecologic Oncology ◽

10.1016/j.ygyno.2013.08.014 ◽

2013 ◽

Vol 131 (2) ◽

pp. 437-444 ◽

Author(s):

Elfriede Greimel ◽

Gunnar B. Kristensen ◽

Maria E.L. van der Burg ◽

Pluvio Coronado ◽

Gordon Rustin ◽

...

Keyword(s):

Quality Of Life ◽

Ovarian Cancer ◽

Adjuvant Chemotherapy ◽

Advanced Ovarian Cancer ◽

Phase Iii ◽

Debulking Surgery ◽

Primary Debulking Surgery ◽

Phase Iii Study ◽

Neo Adjuvant Chemotherapy

Download Full-text

Surrogate endpoint of progression-free (PFS) and overall survival (OS) for advanced ovarian cancer (AOC) patients (pts) treated with neo-adjuvant chemotherapy (NACT): Results of the CHIVA randomized phase II GINECO study

Annals of Oncology ◽

10.1093/annonc/mdz250.024 ◽

2019 ◽

Vol 30 ◽

pp. v415

Author(s):

F. Lecuru ◽

E. Pujade-Lauraine ◽

S. Hamizi ◽

A. Caumont-Prim ◽

N. Raban ◽

...

Keyword(s):

Ovarian Cancer ◽

Overall Survival ◽

Adjuvant Chemotherapy ◽

Phase Ii ◽

Advanced Ovarian Cancer ◽

Surrogate Endpoint ◽

Randomized Phase Ii ◽

Neo Adjuvant Chemotherapy

Download Full-text

No survival benefit with adjuvant chemotherapy in nonserous stage IB grade 2 epithelial ovarian cancer

Gynecologic Oncology ◽

10.1016/j.ygyno.2016.04.161 ◽

2016 ◽

Vol 141 ◽

pp. 53-54

Author(s):

S. Grabosch ◽

J. Berger ◽

M. Huang ◽

S.E. Taylor ◽

J.F. Lin ◽

...

Keyword(s):

Ovarian Cancer ◽

Adjuvant Chemotherapy ◽

Epithelial Ovarian Cancer ◽

Survival Benefit ◽

Download Full-text

Weekly versus 3-weekly paclitaxel in combination with carboplatin in advanced ovarian cancer: which is the optimal adjuvant chemotherapy regimen?

Journal of Gynecologic Oncology ◽

10.3802/jgo.2018.29.e96 ◽

2018 ◽

Vol 29 (6) ◽

Author(s):

Matilda X. Lee ◽

David SP Tan

Keyword(s):

Ovarian Cancer ◽

Adjuvant Chemotherapy ◽

Chemotherapy Regimen ◽

Advanced Ovarian Cancer ◽

Weekly Paclitaxel ◽

Adjuvant Chemotherapy Regimen

Download Full-text